[1].Hemmati, H., Transcriptional analyses of an ethanol inducible promoter in
Escherichia
coliand tobacco for production of cellulase and green fluorescent protein. Biotechnology
&
Biotechnological Equipment& Basu, C. (2015)., 29(6), 1043–1052
[2].Ali, L., Goraya, M. U., Arafat, Y., Ajmal, M., Chen, J. L., & Yu, D. (2017).
Molecular
Mechanism of Quorum-Sensing in Enterococcus faecalis: Its Role in Virulence and
Therapeutic
Approaches. Int J Mol Sci, 18(5).
[3].Gowhari A., Shabgah, Gholizadeh J, et al. Interleukin-22 in human inflammatory
diseases
and viral infections. [J]. Autoimmunity reviews, 2017.
[4].Kong, X., Feng, D., Mathews, S. & Gao, B. Hepatoprotective and anti- fibrotic
functions
of interleukin-22: therapeutic potential for the treatment of alcoholic liver disease.
[J].
Gastroenterol. Hepatol. 28, 56–60 (2013).
[5].Park O, Wang H, Weng H, et al. In vivo consequences of liver specific interleukin-22
expression in mice: Implications for human liver disease progression. [J]. Hepatology,
2011
54(1): 252-261.
[6].Holo, H., Jeknic, Z., Daeschel, M., Stevanovic, S., & Nes, I. F. (2001). Plantaricin
W
from Lactobacillus plantarum belongs to a new family of two-peptide lantibiotics.
Microbiology (Reading, England), 147(Pt 3), 643–651
[7].Sánchez, J., Diep, D. B., Herranz, C., Nes, I. F., Cintas, L. M., & Hernández, P. E.
(2007). Amino acid and nucleotide sequence, adjacent genes, and heterologous expression
of
hiracin JM79, a sec-dependent bacteriocin produced by Enterococcus hirae DCH5, isolated
from
Mallard ducks (Anas platyrhynchos). FEMS microbiology letters, 270(2), 227–236.
[8].Zhang, G., Brokx, S., & Weiner, J. H. (2005). Extracellular accumulation of
recombinant
proteins fused to the carrier protein YebF in Escherichia coli. Nature Biotechnology,
24(1),
100–104.
[9].Munoz-Morris MA, Heitz F, Divita G, et al. The peptide carrier Pep-1 forms
biologically
efficient nanoparticle complexes [J]. Biochem Biophys Res Commun, 2007, 355(4)877-882
[10]https://2018.igem.org/Team:TAS_Taipei/Experiments
[11].Wang, W., Li, Y., Wang, Y., Shi, C., Li, C., Li, Q., & Linhardt, R. J. (2018).
Bacteriophage T7 transcription system: an enabling tool in synthetic biology.
Biotechnology
Advances.
[12].M K, HM S. A portable expression resource for engineering cross-species genetic
circuits and pathways. Nature communications. 2015;6:7832.
[13].Liang, X., et al. (2018). "Integrating T7 RNA Polymerase and Its Cognate
Transcriptional Units for a Host-Independent and Stable Expression System in Single
Plasmid." ACS Synth Biol 7(5): 1424-1435.
[14].Ryan KJ, Ray CG, eds. (2004). Sherris Medical Microbiology (4th ed.). McGraw Hill.
pp.
294–295. ISBN 0-8385-8529-9.
[15].Sánchez, J., Diep, D. B., Herranz, C., Nes, I. F., Cintas, L. M., & Hernández, P.
E.
(2007). Amino acid and nucleotide sequence, adjacent genes, and heterologous expression
of
hiracin JM79, a sec-dependent bacteriocin produced by Enterococcus hirae DCH5, isolated
from
Mallard ducks (Anas platyrhynchos). FEMS microbiology letters, 270(2), 227–236.
[16].Holo, H., Jeknic, Z., Daeschel, M., Stevanovic, S., & Nes, I. F. (2001).
Plantaricin
W
from Lactobacillus plantarum belongs to a new family of two-peptide lantibiotics.
Microbiology (Reading, England), 147(Pt 3), 643–651.
[17].Geldart, K. G., Kommineni, S., Forbes, M., Hayward, M., Dunny, G. M., Salzman, N.
H., &
Kaznessis, Y. N. (2018). Engineered E. coli Nissle 1917 for the reduction of
vancomycin-resistant Enterococcus in the intestinal tract. Bioengineering &
translational
medicine, 3(3), 197–208.
[18].Zhang, G., Brokx, S., & Weiner, J. H. (2006). Extracellular accumulation of
recombinant
proteins fused to the carrier protein YebF in Escherichia coli. Nature biotechnology,
24(1),
100–104.
[19].Cederbaum, A. I. (2012). Alcohol metabolism. Clin Liver Dis, 16(4), 667-685.
[20].Leeman, R. F., Corbin, W. R., Nogueira, C., Krishnan-Sarin, S., Potenza, M. N., &
O'Malley, S. S. (2013). A human alcohol self-administration paradigm to model individual
differences in impaired control over alcohol use. Exp Clin Psychopharmacol, 21(4),
303-314.
[21].Lieber, C. S. (2005). Metabolism of alcohol. Clin Liver Dis, 9(1), 1-35.
[22].Plawecki, M. H., & Crabb, D. W. (2014). Metabolism. Handb Clin Neurol, 125, 55-69.
[23].Singh, J. (2020). Analysis of fractional blood alcohol model with composite
fractional
derivative. Chaos, Solitons & Fractals, 140.
[24].Hu, B. W., Lai, J. H. (1996). STUDY OF ALCOHOL PHARMACOKINETICS IN HUMAN BODY. Chin
J
Forensic Med (01),1-5.
[25].Qiao, L. . (2010). Simulating bioreaction processes based on simbiology. Computer
Applications & Software.
[26].Ali, L., Goraya, M. U., Arafat, Y., Ajmal, M., Chen, J. L., & Yu, D. (2017).
Molecular
Mechanism of Quorum-Sensing in Enterococcus faecalis: Its Role in Virulence and
Therapeutic
Approaches. Int J Mol Sci, 18(5).
[27].Del Papa, M. F., & Perego, M. (2011). Enterococcus faecalis virulence regulator
FsrA
binding to target promoters. J Bacteriol, 193(7), 1527-1532.
[28].Nakayama, J., Cao, Y., Horii, T., Sakuda, S., & Nagasawa, H. (2001). Chemical
synthesis
and biological activity of the gelatinase biosynthesis-activating pheromone of
Enterococcus
faecalis and its analogs. Biosci Biotechnol Biochem, 65(10), 2322-2325.
[29].Rutherford, S. T., & Bassler, B. L. (2012). Bacterial quorum sensing: its role in
virulence and possibilities for its control. Cold Spring Harb Perspect Med, 2(11).
[30].Hämäläinen, M. (2020). The importance of drug-target binding kinetics for drug
efficacy
– Without on you are off!. Retrieved 21 October 2020, from
https://www.cytivalifesciences.co.jp/contact/pdf/L11_32-1351-12AA.pdf
[31].Hussain, R., & Siligardi, G. (2016). Characterisation of Conformational and Ligand
Binding Properties of Membrane Proteins Using Synchrotron Radiation Circular Dichroism
(SRCD). *Advances in experimental medicine and biology*, *922*, 43–59.
[32].Pul, Ü., Lux, B., Wurm, R., & Wagner, R. (2008). Effect of upstream curvature and
transcription factors H-NS and LRP on the efficiency of Escherichia coli rRNA promoters
P1
and P2 - a phasing analysis. Microbiology (Reading, England), 154(Pt 9), 2546–2558.
[33].Kotzsch, A., Vernet, E., Hammarström, M., Berthelsen, J., Weigelt, J., Gräslund,
S., &
Sundström, M. (2011). A secretory system for bacterial production of high-profile
protein
targets. *Protein science : a publication of the Protein Society*, *20*(3), 597–609.
[34].Patching, S. G., Edara, S., Ma, P., Nakayama, J., Hussain, R., Siligardi, G., &
Phillips-Jones, M. K. (2012). Interactions of the intact FsrC membrane histidine kinase
with
its pheromone ligand GBAP revealed through synchrotron radiation circular dichroism.
Biochimica et biophysica acta, 1818(7), 1595–1602.
[35].Pérez-Ortín JE, Alepuz P, Chávez S, Choder M. Eukaryotic mRNA decay: methodologies,
pathways, and links to other stages of gene expression. J Mol Biol. 2013 Oct
23;425(20):3750-75.
[36].Rieu, A., Weidmann, S., Garmyn, D., Piveteau, P., & Guzzo, J. (2007). Agr system of
Listeria monocytogenes EGD-e: role in adherence and differential expression pattern.
*Applied and environmental microbiology*, *73*(19), 6125–6133.
[37].Hui, N. , Min, B. W. , Mei, G. K. , Jun, L. W. , & Chun, H. D. . (2009). The
comparative research on intestinal flora population of patients with colorectal cancer
and
normal people. *Journal of Kunming Medical University*
[38].Xu, M., Chang, B., Mathews, S., & Gao, B. (2014). New drug targets for alcoholic
liver
disease. Hepatology international, 8 Suppl 2(Suppl 2), 475–480.
[39].Xing, W. W., Zou, M. J., Liu, S., Xu, T., Wang, J. X., & Xu, D. G. (2011).
Interleukin-22 protects against acute alcohol-induced hepatotoxicity in mice.
Bioscience,
biotechnology, and biochemistry, 75(7), 1290–1294.
[40].Gao, B., & Shah, V. H. (2015). Combination therapy: New hope for alcoholic
hepatitis?.
Clinics and research in hepatology and gastroenterology, 39 Suppl 1(Suppl 1), S7–S11.
[41].Gao, B. (2012). Hepatoprotective and anti‐inflammatory cytokines in alcoholic liver
disease. Journal of gastroenterology and hepatology, 27, 89-93.
[42].Na, D., Yoo, S. M., Chung, H., Park, H., Park, J. H., & Lee, S. Y. (2013).
Metabolic
engineering of Escherichia coli using synthetic small regulatory RNAs. Nat Biotechnol,
31(2), 170-174. doi:10.1038/nbt.2461
[43].Keane, J., Gershon, S., & Wise, R. (2001). TUBERCULOSIS ASSOCIATED WITH IMFLIXIMAB,
A
TUMOR NECROSIS FACTOR ALPHA-NEUTRALIZING AGENT. Infectious Diseases In Clinical
Practice,
10(9), 498. doi: 10.1097/00019048-200112000-00012
[44].Nowotarski, S. L., & Shantz, L. M. (2010). Cytoplasmic accumulation of the
RNA-binding
protein HuR stabilizes the ornithine decarboxylase transcript in a murine nonmelanoma
skin
cancer model. The Journal of biological chemistry, 285(41), 31885–31894.
[45].Emerald, B. S., Chen, Y., Zhu, T., Zhu, Z., Lee, K. O., Gluckman, P. D., & Lobie,
P. E.
(2007). AlphaCP1 mediates stabilization of hTERT mRNA by autocrine human growth hormone.
The
Journal of biological chemistry, 282(1), 680–690.
[46].Geva-Zatorsky, N., Issaeva, I., Mayo, A. et al. Using bleach-chase to measure
protein
half-lives in living cells. Nat Protoc 7, 801–811 (2012).